Cargando…

Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Akram, Javed, Azhar, Shehnoor, Shahzad, Muhammad, Latif, Waqas, Khan, Khalid Saeed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442885/ https://www.ncbi.nlm.nih.gov/pubmed/32828129 http://dx.doi.org/10.1186/s13063-020-04697-1

Ejemplares similares

Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial
por: Akram, Javed, et al.
Publicado: (2022)

Protocol of Pakistan randomized and observational trial to evaluate coronavirus treatment among newly diagnosed patients with COVID-19: Azithromycin, Oseltamivir, and Hydroxychloquine
por: Azhar, Shehnoor, et al.
Publicado: (2022)

Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trial
por: Akram, Javed, et al.
Publicado: (2020)

Azithromycin/hydroxychloroquine/oseltamivir: Erythema multiforme major: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine/oseltamivir: Urticarial reactions following off label use: case report
Publicado: (2020)

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
por: Gautret, Philippe, et al.
Publicado: (2020)

Hydroxychloroquine versus Azithromycin for Hospitalized Patients with COVID-19. Results of a Randomized, Active Comparator Trial
por: Brown, Samuel M., et al.
Publicado: (2021)

Patient safety attitudes of frontline healthcare workers in Lahore: A multicenter study
por: Arkam, Javed, et al.
Publicado: (2022)

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited
por: Gautret, Philippe, et al.
Publicado: (2021)

Efficacy of Combination Therapy with Oseltamivir Phosphate and Azithromycin for Influenza: A Multicenter, Open-Label, Randomized Study
por: Kakeya, Hiroshi, et al.
Publicado: (2014)

Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19
por: Omrani, Ali S., et al.
Publicado: (2020)

Referring to the study: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial
por: dos Santos, Marcelo Rodrigues
Publicado: (2021)

Summary of adverse drug events for hydroxychloroquine, azithromycin, and chloroquine during the COVID-19 pandemic
por: Dauner, Daniel G., et al.
Publicado: (2021)

Hydroxychloroquine/oseltamivir: Junctional rhythm and bradycardia: case report
Publicado: (2021)

Letter to the editor about “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial”
por: Saad, Mohamed O
Publicado: (2021)

Focus on clinical outcomes of “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial”
por: Wambier, Carlos Gustavo
Publicado: (2021)

Hydroxychloroquine safety: A meta-analysis of randomized controlled trials
por: Eljaaly, Khalid, et al.
Publicado: (2020)

Hydroxychloroquine- and azithromycin-related heart disorders
Publicado: (2020)

Hydroxychloroquine + azithromycin treatment in elderly patients
por: Gautret, Philippe, et al.
Publicado: (2021)

Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
Publicado: (2022)

Commentary on “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial” by Gautret et al
por: Toumi, Mondher, et al.
Publicado: (2020)

Doxycycline vs Hydroxychloroquine + Azithromycin in the Management of COVID-19 Patients: An Open-Label Randomized Clinical Trial in Sub-Saharan Africa (DOXYCOV)
por: Sobngwi, Eugene, et al.
Publicado: (2023)

QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020)

Excessive lysosomal ion-trapping of hydroxychloroquine and azithromycin
por: Derendorf, Hartmut
Publicado: (2020)

Hydroxychloroquine-azithromycin for COVID-19 – Warranted or dangerous?
por: Popescu, Corneliu P., et al.
Publicado: (2020)

Hydroxychloroquine and azithromycin as a treatment of COVID-19
por: Fanin, Alice, et al.
Publicado: (2020)

Use of hydroxychloroquine and chloroquine in COVID-19: How good is the quality of randomized controlled trials?
por: Mazhar, Faizan, et al.
Publicado: (2020)

Randomized Trial of Erythromycin and Azithromycin for Treatment of Chlamydial Infection in Pregnancy
por: Rosenn, Marc F., et al.
Publicado: (1995)

Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial
por: Johnston, Christine, et al.
Publicado: (2021)

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
por: Axfors, Cathrine, et al.
Publicado: (2021)

Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes
por: Gautret, Philippe, et al.
Publicado: (2021)

Therapies to Prevent Progression of COVID-19, Including Hydroxychloroquine, Azithromycin, Zinc, and Vitamin D3 With or Without Intravenous Vitamin C: An International, Multicenter, Randomized Trial
por: Ried, Karin, et al.
Publicado: (2021)

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
por: Boulware, David R., et al.
Publicado: (2020)

A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19
por: Mitjà, Oriol, et al.
Publicado: (2020)

Hydroxychloroquine/oseltamivir: Various toxicity following off label therapy: case report
Publicado: (2020)

Hydroxychloroquine/oseltamivir: Exacerbation of psoriasis during off-label use: case report
Publicado: (2020)

Hydroxychloroquine/oseltamivir: Complete heart block and premature ventricular contractions: case report
Publicado: (2021)

Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19
por: Albani, Filippo, et al.
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc interval prolongation: case report
Publicado: (2020)

Anticoagulants/azithromycin/hydroxychloroquine: Spontaneous haematoma: case report
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v8sv8dn0bbv6btdjaud1huud2e